Is OpenEvidence Free? What It Costs and How It Fits Prescribing

The short answer: yes, OpenEvidence is free for verified clinicians. In the US, verification is tied to your NPI, and the service is funded by advertising and journal partnerships rather than subscriptions. You ask a clinical question in plain language and it answers by summarizing the peer-reviewed literature with citations you can open. There is no consumer paywall and no per-question charge. The honest caveat is what "free" pays for: it is an ad-supported evidence-summary tool, and it answers clinical questions rather than running the interaction and dosing checks on the prescription in front of you.

OpenEvidence has grown quickly, and clinicians keep asking the same two things: is it really free, and is it good enough to rely on. Here is a straight answer to both.

Is OpenEvidence really free?

Yes, for clinicians who complete verification. OpenEvidence offers free access to clinicians who confirm they are practicing professionals, which in the US is based on your NPI. The company funds the free access through advertising and partnerships with medical publishers rather than by charging users. That is a real business model, not a limited trial, and it is why a lot of clinicians have been able to add it to their workflow at no cost.

The thing to weigh is not a hidden fee. It is the ad-supported model itself: the product is free to you because it is monetized another way. For many clinicians that trade is entirely fine. It is worth being aware of, the same way you would be with any free professional tool.

How does OpenEvidence work?

You type a clinical question the way you would ask a colleague, and it returns a synthesized answer drawn from the medical literature, with citations to the underlying papers and guidelines. It is closer to an AI-assisted literature search than to a drug reference. For background questions, "what does the evidence say about X," that format is genuinely useful, and the citations let you check the source rather than take the summary on faith.

What it is not built to do is watch a specific prescription. It answers the clinical question; it does not take a patient's medication list and tell you that the drug you are about to add interacts with three of them, or that their renal function makes the standard dose wrong. Those are different jobs, and it is fair to the tool to judge it on the one it is designed for.

Is OpenEvidence reliable for clinical use?

It is a useful evidence-summary tool, with the standard caveat that applies to any AI system: verify before you act. Because it cites its sources, you can and should open the citation and confirm the summary reflects it, especially for a consequential decision. Used that way, as a fast way to surface and read the relevant literature rather than as a final authority, it is reliable enough to be worth having. Used as an oracle you trust without checking, no AI tool clears that bar, and OpenEvidence does not claim to.

The mental model that keeps you safe is simple. Treat it as a well-read assistant that hands you the papers, not as a clinician that makes the call. You still make the call.

Is OpenEvidence better than UpToDate?

They are built for different things, so "better" depends on the question. UpToDate is a paid editorial operation whose topics are written and graded by named physician authors, and clinicians pay for that graded, defensible position. OpenEvidence is a free, AI-driven literature summary that is fast and broad but does not carry the same editorial grading. For a quick read of the evidence, OpenEvidence is often enough and costs nothing; for a decision you have to defend in a case review, the graded reference still has a role. We put the two side by side in detail in UpToDate vs OpenEvidence.

What OpenEvidence does not do at the point of prescribing

Here is the gap that matters for prescribers. An evidence engine answers the clinical question, but the prescription in front of you raises several safety questions at once: does this interact with what the patient already takes, is it contraindicated, does a documented allergy block it, and does their kidney or liver function change the dose. Answering those by asking a literature tool one at a time is slow, and the check that gets skipped is the one nobody thought to run.

That is the job a point-of-care decision-support tool is built for. Prescriber.io takes the drug or the scenario once and returns the interaction check, the contraindication and allergy flags, the renal and hepatic dose adjustments and the guideline-based alternatives together in one card, with sources cited on each flag. It is decision-support for licensed clinicians, not autonomous prescribing: every flag is a prompt you review, verify against official sources, and sign off on. Many clinicians will reasonably use both, an evidence engine for the background reading and a decision-support card at the moment of prescribing.

Do you have to verify your NPI to use it?

To get the free clinician access, yes, you go through a verification step, and in the US that is tied to your NPI. This is deliberate. The free, ad-supported model is aimed at practicing clinicians, and verification is how the service confirms the audience it is built and monetized for. It also means the medical content is not being served to the general public as consumer health advice, which is the right call for a tool that summarizes prescribing-relevant literature.

For a licensed US clinician the step is quick and one-time. If you are a student or in training, check the current verification terms, since eligibility for professional tools can differ for trainees. The broader point is that OpenEvidence being free does not mean it is open to everyone; it is free to the verified clinical audience it targets.

Who is OpenEvidence best for?

It fits clinicians who want a fast way to read what the evidence says without running a full literature search themselves. If your daily friction is "I need the current thinking on this condition, with sources, in the next two minutes," an AI evidence summary handles that well and costs nothing. Residents and clinicians keeping up across a broad range of presentations tend to get the most out of it, because the breadth is the point.

It is a weaker fit if what you actually need is the safety check on a specific prescription. That is a structured, per-patient task, not a literature question, and it is worth pairing an evidence engine with a tool built for the prescribing moment rather than asking one to do the other's job.

The bottom line

OpenEvidence is free for verified US clinicians, funded by advertising and journal partnerships, and it is a genuinely useful way to summarize the literature with citations you can verify. Keep the ad-supported model in mind, verify anything consequential against the cited source, and remember that answering a clinical question and checking a prescription are two different tasks. You can run the prescription check yourself at the top of this page.